GastroDose

The TIMERx® oral controlled release delivery system allows Penwest to modify the release of drugs to provide a therapeutic benefit to patients by delivering medicines that are more efficacious and provide greater patient compliance. The technology is cost-effective and easy to scale-up and manufacture.

This sophisticated yet simple delivery technology precisely and predictably controls drug release and can provide a range of benefits - reduce dosing frequency, improve drug performance and compliance, minimize side effects, achieve new indications, and optimize the performance of chemical entities.

The TIMERx oral drug delivery system achieves a variety of release profiles (First order, Zero order, BurstCR, etc.) for a wide range of drugs, accommodating even the most difficult actives.

TIMERx can be used in:

  • Low to high dose drugs
  • Insoluble to highly-soluble drugs
  • Drugs with short half-life and/or narrow therapeutic window

    TIMERx enables Penwest to meet the significant challenges of today's pharmaceutical marketplace head-on with 32 U.S. issued patents and 178 patents worldwide.


  • 2008 Penwest Pharmaceuticals Co.
    Terms and Conditions, Privacy Statement, & Safe Harbor